Why is Natco Pharma falling/rising?

As of 16-Jul, Natco Pharma Ltd. is experiencing a price increase, currently at 1,020.30, reflecting a rise of 9.4 points or 0.93%. The stock has been gaining momentum over the last three days, with a total return of 6.09% during this period. It outperformed its sector by 1.2% today and reached an intraday high of Rs 1,046.8. Despite a year-to-date decline of 26.44%, the stock has shown a positive trend in the short term, with a 13.05% increase over the past month. The company's strong fundamentals, including a high return on equity (ROE) of 15.57% and a low debt-to-equity ratio, contribute to its attractiveness, especially as it trades at a discount compared to its peers. Additionally, the stock's healthy long-term growth, evidenced by a 32.35% annual growth rate in operating profit, supports its recent price movement.
In the broader market context, Natco Pharma's short-term performance contrasts with the Sensex, which has declined by 1.08% over the past week. While the stock has shown resilience and positive returns in the short term, it still lags behind the benchmark with a year-to-date performance that is significantly lower than the Sensex's 5.75% gain. The rising investor participation, indicated by a 13.8% increase in delivery volume, along with high institutional holdings at 23.15%, suggests that informed investors are confident in the company's potential, further bolstering the stock's upward movement.